EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 3.0

Engineering geniposide-loaded solid lipid nanoparticles for sustained release and induced apoptosis in human lung cancer cells

Saumyadeep Bora, Bhavana Jodha, Raju Vidap, Sunita Patel, Deep Pooja, Hitesh Kulhari

RSC Pharmaceutics · 2026 · 3 (5) · 1229-1239

DOI: 10.1039/d6pm00179c ↗

Kurz gefasst

Fachartikel in der Zeitschrift RSC Pharmaceutics, 2026. Verfasst von Saumyadeep Bora und 5 weiteren Autor:innen. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Geniposide-loaded solid lipid nanoparticles (GSLN) improved intracellular drug delivery and sustained drug release, resulting in enhanced anticancer efficacy in A549 NSCLC cells as compared to pure geniposide.

Zitieren

APA

Bora, S., Jodha, B., Vidap, R., Patel, S., Pooja, D., & Kulhari, H. (2026). Engineering geniposide-loaded solid lipid nanoparticles for sustained release and induced apoptosis in human lung cancer cells. RSC Pharmaceutics, 3(5), 1229-1239. https://doi.org/10.1039/d6pm00179c

Vancouver

Bora S, Jodha B, Vidap R, Patel S, Pooja D, Kulhari H. Engineering geniposide-loaded solid lipid nanoparticles for sustained release and induced apoptosis in human lung cancer cells. RSC Pharmaceutics. 2026;3(5):1229-1239. doi:10.1039/d6pm00179c

BibTeX
@article{Bora2026,
  author = {Bora, Saumyadeep and Jodha, Bhavana and Vidap, Raju and Patel, Sunita and Pooja, Deep and Kulhari, Hitesh},
  title = {Engineering geniposide-loaded solid lipid nanoparticles for sustained release and induced apoptosis in human lung cancer cells},
  journal = {RSC Pharmaceutics},
  year = {2026},
  volume = {3},
  number = {5},
  pages = {1229--1239},
  doi = {10.1039/d6pm00179c}
}
Kostenlos starten →